Molecularly Guided Drug Repurposing for Cholangiocarcinoma: An Integrative Bioinformatic Approach

Genes(2023)

引用 4|浏览7
暂无评分
摘要
This study proposes the use of the immune-oncogenic gene signature to identify high-risk CCA patients. Future preclinical and clinical studies are required to elucidate the therapeutic efficacy of the molecularly guided drugs as the adjunct therapy, aiming to improve the survival outcome.
更多
查看译文
关键词
cholangiocarcinoma,connectivity map,drug repurposing,drug–gene network,immune-oncogenic gene signature,survival analysis,transcriptomics
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要